Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T, Noguera R, Parodi S, Schleiermacher G, Tweddle DA, Valent A, Van Roy N, Vicha A, Villamon E, Tonini GP.

Br J Cancer. 2014 Nov 4. doi: 10.1038/bjc.2014.557. [Epub ahead of print]

PMID:
25356804
[PubMed - as supplied by publisher]
2.

Intragenic anaplastic lymphoma kinase (ALK) rearrangements: Translocations as a novel mechanism of ALK activation in neuroblastoma tumors.

Fransson S, Hansson M, Ruuth K, Djos A, Berbegall A, Javanmardi N, Abrahamsson J, Palmer RH, Noguera R, Hallberg B, Kogner P, Martinsson T.

Genes Chromosomes Cancer. 2014 Sep 23. doi: 10.1002/gcc.22223. [Epub ahead of print]

PMID:
25251827
[PubMed - as supplied by publisher]
3.

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers.

Oberthuer A, Juraeva D, Hero B, Volland R, Carolina S, Schmidt R, Faldum A, Kahlert Y, Engesser A, Asgharzadeh S, Seeger RC, Ohira M, Nakagawara A, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Speleman F, Noguera R, Piqueras M, Benard J, Valent A, Avigad S, Yaniv I, Grundy RG, Ortmann M, Shao C, Schwab M, Eils R, Simon T, Theissen J, Berthold F, Westermann F, Brors B, Fischer M.

Clin Cancer Res. 2014 Sep 17. pii: clincanres.0817.2014. [Epub ahead of print]

PMID:
25231397
[PubMed - as supplied by publisher]
4.

Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours.

Braekeveldt N, Wigerup C, Gisselsson D, Mohlin S, Merselius M, Beckman S, Jonson T, Börjesson A, Backman T, Tadeo I, Berbegall AP, Ora I, Navarro S, Noguera R, Påhlman S, Bexell D.

Int J Cancer. 2014 Sep 15. doi: 10.1002/ijc.29217. [Epub ahead of print]

PMID:
25220031
[PubMed - as supplied by publisher]
5.

Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration.

Berbegall AP, Villamón E, Tadeo I, Martinsson T, Cañete A, Castel V, Navarro S, Noguera R.

Neoplasia. 2014 Jun;16(6):471-80. doi: 10.1016/j.neo.2014.05.012.

PMID:
25077701
[PubMed - in process]
Free PMC Article
6.

Glycosaminoglycan profiling in different cell types using infrared spectroscopy and imaging.

Brézillon S, Untereiner V, Lovergne L, Tadeo I, Noguera R, Maquart FX, Wegrowski Y, Sockalingum GD.

Anal Bioanal Chem. 2014 Sep;406(24):5795-803. doi: 10.1007/s00216-014-7994-2. Epub 2014 Jul 15.

PMID:
25023968
[PubMed - in process]
7.

Biotensegrity of the extracellular matrix: physiology, dynamic mechanical balance, and implications in oncology and mechanotherapy.

Tadeo I, Berbegall AP, Escudero LM, Alvaro T, Noguera R.

Front Oncol. 2014 Mar 4;4:39. doi: 10.3389/fonc.2014.00039. eCollection 2014. Review.

PMID:
24624363
[PubMed]
Free PMC Article
8.

TMA vessel segmentation based on color and morphological features: application to angiogenesis research.

Fernández-Carrobles MM, Tadeo I, Bueno G, Noguera R, Déniz O, Salido J, García-Rojo M.

ScientificWorldJournal. 2013 Dec 5;2013:263190. doi: 10.1155/2013/263190. eCollection 2013.

PMID:
24489494
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.

Rihani A, Van Maerken T, De Wilde B, Zeka F, Laureys G, Norga K, Tonini GP, Coco S, Versteeg R, Noguera R, Schulte JH, Eggert A, Stallings RL, Speleman F, Vandesompele J.

Pediatr Blood Cancer. 2014 Oct;61(10):1867-70. doi: 10.1002/pbc.24927. Epub 2014 Jan 4.

PMID:
24391119
[PubMed - indexed for MEDLINE]
10.

Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma.

Tadeo I, Piqueras M, Montaner D, Villamón E, Berbegall AP, Cañete A, Navarro S, Noguera R.

Pediatr Res. 2014 Feb;75(2):302-14. doi: 10.1038/pr.2013.217. Epub 2013 Nov 11.

PMID:
24216542
[PubMed - indexed for MEDLINE]
11.

snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.

von Stedingk K, Koster J, Piqueras M, Noguera R, Navarro S, Påhlman S, Versteeg R, Ora I, Gisselsson D, Lindgren D, Axelson H.

Transl Oncol. 2013 Aug 1;6(4):447-57. Print 2013 Aug.

PMID:
23908688
[PubMed]
Free PMC Article
12.

New prognostic markers in neuroblastoma.

Navarro S, Piqueras M, Villamón E, Yáñez Y, Balaguer J, Cañete A, Noguera R.

Expert Opin Med Diagn. 2012 Nov;6(6):555-67. doi: 10.1517/17530059.2012.704018. Epub 2012 Jul 11.

PMID:
23480837
[PubMed]
13.

Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.

Villamón E, Berbegall AP, Piqueras M, Tadeo I, Castel V, Djos A, Martinsson T, Navarro S, Noguera R.

PLoS One. 2013;8(1):e53740. doi: 10.1371/journal.pone.0053740. Epub 2013 Jan 14.

PMID:
23341988
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.

Kumps C, Fieuw A, Mestdagh P, Menten B, Lefever S, Pattyn F, De Brouwer S, Sante T, Schulte JH, Schramm A, Van Roy N, Van Maerken T, Noguera R, Combaret V, Devalck C, Westermann F, Laureys G, Eggert A, Vandesompele J, De Preter K, Speleman F.

PLoS One. 2013;8(1):e52321. doi: 10.1371/journal.pone.0052321. Epub 2013 Jan 4.

PMID:
23308108
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

NeuPAT: an intranet database supporting translational research in neuroblastic tumors.

Villamón E, Piqueras M, Meseguer J, Blanquer I, Berbegall AP, Tadeo I, Hernández V, Navarro S, Noguera R.

Comput Biol Med. 2013 Mar;43(3):219-28. doi: 10.1016/j.compbiomed.2012.11.011. Epub 2013 Jan 4.

PMID:
23290604
[PubMed - indexed for MEDLINE]
16.

Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome.

Schramm A, Schowe B, Fielitz K, Heilmann M, Martin M, Marschall T, Köster J, Vandesompele J, Vermeulen J, de Preter K, Koster J, Versteeg R, Noguera R, Speleman F, Rahmann S, Eggert A, Morik K, Schulte JH.

Br J Cancer. 2012 Oct 9;107(8):1409-17. doi: 10.1038/bjc.2012.391.

PMID:
23047593
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Decock A, Ongenaert M, Hoebeeck J, De Preter K, Van Peer G, Van Criekinge W, Ladenstein R, Schulte JH, Noguera R, Stallings RL, Van Damme A, Laureys G, Vermeulen J, Van Maerken T, Speleman F, Vandesompele J.

Genome Biol. 2012 Oct 3;13(10):R95. doi: 10.1186/gb-2012-13-10-r95.

PMID:
23034519
[PubMed - in process]
Free PMC Article
18.

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.

Schleiermacher G, Mosseri V, London WB, Maris JM, Brodeur GM, Attiyeh E, Haber M, Khan J, Nakagawara A, Speleman F, Noguera R, Tonini GP, Fischer M, Ambros I, Monclair T, Matthay KK, Ambros P, Cohn SL, Pearson AD.

Br J Cancer. 2012 Oct 9;107(8):1418-22. doi: 10.1038/bjc.2012.375. Epub 2012 Sep 13.

PMID:
22976801
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Extracellular matrix, biotensegrity and tumor microenvironment. An update and overview.

Noguera R, Nieto OA, Tadeo I, Fariñas F, Alvaro T.

Histol Histopathol. 2012 Jun;27(6):693-705. Review.

PMID:
22473691
[PubMed - indexed for MEDLINE]
20.

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Schleiermacher G, Michon J, Ribeiro A, Pierron G, Mosseri V, Rubie H, Munzer C, Bénard J, Auger N, Combaret V, Janoueix-Lerosey I, Pearson A, Tweddle DA, Bown N, Gerrard M, Wheeler K, Noguera R, Villamon E, Cañete A, Castel V, Marques B, de Lacerda A, Tonini GP, Mazzocco K, Defferrari R, de Bernardi B, di Cataldo A, van Roy N, Brichard B, Ladenstein R, Ambros I, Ambros P, Beiske K, Delattre O, Couturier J.

Br J Cancer. 2011 Dec 6;105(12):1940-8. doi: 10.1038/bjc.2011.472. Epub 2011 Nov 10.

PMID:
22146831
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk